Oral insulin delivery

Advanced Drug Delivery Reviews

Volumn 35, Issue 2-3, 1999, Pages 249-257

  Carino, Gerardo P ^a   Mathiowitz, Edith ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Diabetes; Enteric coatings; Microspheres; Permeation enhancers; pH sensitive polymers; Protease inhibitors

Indexed keywords

ANTIDIABETIC AGENT; INSULIN; MICROSPHERE; POLYMER; PROTEINASE INHIBITOR;

DIABETES MELLITUS; DRUG DELIVERY SYSTEM; ENTERIC COATED TABLET; ORAL DRUG ADMINISTRATION; PERMEABILITY; PRIORITY JOURNAL; REVIEW;

EID: 0032968934     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(98)00075-1     Document Type: Review

References (27)

1. D.W. Foster, Diabetes mellitus, in: A.S. Fauci, E. Braunwald, K.J. Isselbacher et al. (Eds.), Harrison's Principles of Internal Medicine, 14th ed, McGraw-Hill, New York, 1998, pp. 2060-2080.
2. C.R. Kahn, Y. Shechter, Insulin, oral hypoglycemic agents, and the pharmacology of the endocrine pancreas, in: A.G. Gilman, T.W. Rall, A.S. Nies, P. Taylor (Eds.), The Pharmacological Basis of Therapeutics, 8th ed., Pergamon Press, New York, 1991, pp. 1463-1495.
3. DCCT: The Diabetes Control and Complications Trial Research Group, The effect of intensive treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus, New Engl. J. Med. 329 (1993) 977-986.
4. Pauletti G., Gangwar S., Knipp G.T., Nerurkar M.M., Okuma F.W., Tamura K., Siahaan T.J., Borchardt R.T. Structural requirements for intestinal absorption of peptide drugs. J. Control. Release. 41:1996;3-17.
5. Moriya H., Moriwaki C., Akimote S., Yamaguchi K., Iwadareet M. Studies on the passage of alpha-chymotrypsin across the intestine. Chem. Pharm. Bull. 15:1967;1662-1668.
6. Wang W. Oral protein delivery. J. Drug Target. 4:1996;195-232.
7. A.C. Guyton, Digestion and absorption in the gastrointestinal tract; gastrointestinal disorders, in: Human Physiology and Mechanisms of Disease, 5th ed., W.B. Saunders, Philadelphia, 1992, pp. 500-509.
8. Bai J.P.F., Chang L.L. Transepithelial transport of insulin: I. Insulin degradation by insulin-degrading enzyme in small intestinal epithelium. Pharm. Res. 12:1995;1171-1175.
9. S.P. Schwendeman, M. Cardamone, A. Klibanov, R. Langer, Stability of proteins and their delivery from biodegradable polymer microspheres, in: S. Cohen, H. Bernstein (Eds.), Microparticulate Systems for the Delivery of Proteins and Vaccines, Marcel Dekker, New York, 1996, pp. 1-49.
10. Mesiha M., Plakogiannis F., Vejosoth S. Enhanced oral absorption of insulin from desolvated fatty acid-sodium glycocholate emulsions. Int. J. Pharm. 111:1994;213-216.
11. Fasano A., Uzzau S. Modulation of intestinal tight junctions by zona occludens toxin permits enteral administration of insulin and other macromolecules in an animal model. J. Clin. Invest. 99:1997;1158-1164.
12. Touitou E., Rubinstein A. Targeted enteral delivery of insulin to rats. Int. J. Pharm. 30:1986;95-99.
13. 2 EDTA and sodium glycocholate on the intestinal absorption of insulin. Biol. Pharm. Bull. 16:1993;68-72.
14. Gwinup G., Elias A.N., Domurat E.S. Insulin and C-peptide levels following oral administration of insulin in intestinal-enzyme protected capsules. Gen. Pharmacol. 22:1991;243-246.
15. Yamamoto A., Taniguchi T., Rikyuu K., Tsuji T., Fujita T., Murakami M., Muranishiet S. Effects of various protease inhibitors on the intestinal absorption and degradation of insulin in rats. Pharm. Res. 11:1994;1496-1500.
16. Morishita I., Morishita M., Takayama K., Machida Y., Nagai T. Enteral insulin delivery by microspheres in 3 different formulations using Eudragit L100 and S100. Int. J. Pharm. 93:1993;29-37.
17. Hosny E.A., Ghilzai N.M.K., Al-Dhawalie A.H. Effective intestinal absorption of insulin in diabetic rats using enteric coated capsules containing sodium salicylate. Drug Dev. Ind. Pharm. 21:1995;1583-1589.
18. Ziv E., Lior O., Kidron M. Absorption of protein via the intestinal wall. Biochem. Pharm. 36:1987;1035-1039.
19. Pappo J., Ermak T.H. Uptake and translocation of fluorescent latex particles by rabbit Peyer's patch follicle epithelium: a quantitative model for M cell uptake. Clin. Exp. Immunol. 76:1989;144-148.
20. Ermak T.H., Dougherty E.P., Bhagat H.R., Kabok Z., Pappo J. Uptake and transport of copolymer biodegradable microspheres by rabbit Peyer's patch M cells. Cell Tissue Res. 279:1995;433-436.
21. Hodges G.M., Carr E.A., Hazzard R.A., Carr K.A. Uptake and translocation of microparticles in small intestine. Dig. Dis. Sci. 40:1995;967-975.
22. Jani P., Halbert G.W., Langridge J., Florence A.T. The uptake and translocation of latex nanospheres and microspheres after oral administration to rats. J. Pharm. Pharmacol. 41:1989;809-812.
23. Mathiowitz E., Jacob J.S., Jong Y.S., Carino G.P., Chickering D., Santos C., Chaturvedi Vijayaraghavan K., Bassett M., Montgomery S., Morrell C. Biologically erodable microspheres as potential oral drug delivery systems. Nature. 386:1997;410-414.
24. Damge C., Michel C., Aprahamian A., Couvreur P., Devissaguetet J.P. Nanocapsules as carriers for oral peptide delivery. J. Control. Release. 13:1990;233-239.
25. Damge C., Michel C., Aprahamian A., Couvreur P., Devissaguetet J.P. Advantage of a new colloidal drug delivery system in the insulin treatment of streptozotocin-induced diabetic rats. Diabetologia. 29:1986;531A.
26. Couvreur P., Lenaerts V., Kante B., Roland K., Speiseret P. Oral and parenteral administration of insulin associated to hydrolyzable nanoparticles. Acta Pharm. Tech. 26:1980;220-222.
27. Damge C., Michael C., Aprahamian M., Couvreur P. New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as oral carrier. Diabetes. 37:1988;247-251.